LEVERONE JASON A. (Chief Financial Officer) sold 19.1% of their position (3.12K shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/8/2025ACC: 0001415889-25-010418
Officer· Chief Financial Officer
Since Oct 2024
-3.12K
Net shares
Net seller
$9.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.12K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−1.28K
Price / share
$3.33
Trade value
$4.25K
% of position
7.8%
4/4/2025
16.33K→15.05K
Class A Common Stock
Direct
Shares
−1.84K
Price / share
$2.67
Trade value
$4.93K
% of position
12.3%
4/7/2025
15.05K→13.21K
Total
Net shares
−3.12K
Net value
-$9.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 4/4/2025 | S · Sale | −1.28K | $3.33 | $4.25K | 7.8% | 16.33K | 15.05K |
| Class A Common Stock Direct | 4/7/2025 | S · Sale | −1.84K | $2.67 | $4.93K | 12.3% | 15.05K | 13.21K |
| Total | −3.12K | -$9.18K | ||||||
Derivative Transactions0
No derivative transactions reported